Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.
Neurology
; 99(12): 511-515, 2022 Sep 20.
Article
in En
| MEDLINE
| ID: mdl-35851255
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunotherapy, Adoptive
/
Lymphoma, B-Cell
/
Receptors, Chimeric Antigen
Limits:
Humans
Language:
En
Journal:
Neurology
Year:
2022
Document type:
Article
Country of publication:
United States